Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Gennarelli

Showing results (181-190 of 213) with videos related to

Pageof 22
Sort By:
Scientific Reports|May 10, 2020
Assessment of haptoglobin alleles in autism spectrum disordersFrancesca Anna Cupaioli, Ettore Mosca, Chiara Magri, et al.
Brain, Behavior, and Immunity|March 18, 2018
Immune and metabolic alterations in first episode psychosis (FEP) patientsLuisella Bocchio-Chiavetto, Roberta Zanardini, Sarah Tosato, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|October 1, 2025
Genome-wide methylation biomarkers and biological aging in patients with bipolar disorder characterized for lithium responseClaudia Pisanu, Alessandra Minelli, Donatella Congiu, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 22, 2025
Corrigendum to "A naturalistic retrospective evaluation of the utility of pharmacogenetic testing based on CYP2D6 and CYP2C19 profiling in antidepressants treatment in a cohort of patients with major depressive disorder" [Progress in Neuropsychopharmacology and Biological Psychiatry (2025) 111292]Alessio Squassina, Pasquale Paribello, Marco Pinna, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|February 19, 2025
A naturalistic retrospective evaluation of the utility of pharmacogenetic testing based on CYP2D6 e CYP2C19 profiling in antidepressants treatment in a cohort of patients with major depressive disorderAlessio Squassina, Pasquale Paribello, Marco Pinna, et al.
Neurobiology of Aging|January 18, 2005
Genotypes and haplotypes in the IL-1 gene cluster: analysis of two genetically and diagnostically distinct groups of Alzheimer patientsDavide Seripa, Maria G Matera, Gloria Dal Forno, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 11, 2022
Transcriptional biomarkers of response to pharmacological treatments in severe mental disorders: A systematic reviewClaudia Pisanu, Giovanni Severino, Ilario De Toma, et al.
Journal of Alzheimer'S Disease : JAD|December 12, 2018
Next Generation Sequencing Analysis in Early Onset Dementia PatientsCristian Bonvicini, Catia Scassellati, Luisa Benussi, et al.
Glia|October 12, 2020
Extracellular clusterin limits the uptake of α-synuclein fibrils by murine and human astrocytesAlice Filippini, Veronica Mutti, Gaia Faustini, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 29, 2021
A meta-analysis of polygenic risk scores for mood disorders, neuroticism, and schizophrenia in antidepressant responseGiuseppe Fanelli, Katharina Domschke, Alessandra Minelli, et al.
Pageof 22

Showing results (181-190 of 213) with videos related to

Sort By:
Pageof 22
Scientific Reports|May 10, 2020
Assessment of haptoglobin alleles in autism spectrum disordersFrancesca Anna Cupaioli, Ettore Mosca, Chiara Magri, et al.
Brain, Behavior, and Immunity|March 18, 2018
Immune and metabolic alterations in first episode psychosis (FEP) patientsLuisella Bocchio-Chiavetto, Roberta Zanardini, Sarah Tosato, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|October 1, 2025
Genome-wide methylation biomarkers and biological aging in patients with bipolar disorder characterized for lithium responseClaudia Pisanu, Alessandra Minelli, Donatella Congiu, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 22, 2025
Corrigendum to "A naturalistic retrospective evaluation of the utility of pharmacogenetic testing based on CYP2D6 and CYP2C19 profiling in antidepressants treatment in a cohort of patients with major depressive disorder" [Progress in Neuropsychopharmacology and Biological Psychiatry (2025) 111292]Alessio Squassina, Pasquale Paribello, Marco Pinna, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|February 19, 2025
A naturalistic retrospective evaluation of the utility of pharmacogenetic testing based on CYP2D6 e CYP2C19 profiling in antidepressants treatment in a cohort of patients with major depressive disorderAlessio Squassina, Pasquale Paribello, Marco Pinna, et al.
Neurobiology of Aging|January 18, 2005
Genotypes and haplotypes in the IL-1 gene cluster: analysis of two genetically and diagnostically distinct groups of Alzheimer patientsDavide Seripa, Maria G Matera, Gloria Dal Forno, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 11, 2022
Transcriptional biomarkers of response to pharmacological treatments in severe mental disorders: A systematic reviewClaudia Pisanu, Giovanni Severino, Ilario De Toma, et al.
Journal of Alzheimer'S Disease : JAD|December 12, 2018
Next Generation Sequencing Analysis in Early Onset Dementia PatientsCristian Bonvicini, Catia Scassellati, Luisa Benussi, et al.
Glia|October 12, 2020
Extracellular clusterin limits the uptake of α-synuclein fibrils by murine and human astrocytesAlice Filippini, Veronica Mutti, Gaia Faustini, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 29, 2021
A meta-analysis of polygenic risk scores for mood disorders, neuroticism, and schizophrenia in antidepressant responseGiuseppe Fanelli, Katharina Domschke, Alessandra Minelli, et al.
Pageof 22